HK1218416A1 - 布魯頓氏酪氨酸激酶抑制劑 - Google Patents
布魯頓氏酪氨酸激酶抑制劑Info
- Publication number
- HK1218416A1 HK1218416A1 HK16106435.2A HK16106435A HK1218416A1 HK 1218416 A1 HK1218416 A1 HK 1218416A1 HK 16106435 A HK16106435 A HK 16106435A HK 1218416 A1 HK1218416 A1 HK 1218416A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- inhibitors
- tyrosine kinase
- brutons tyrosine
- brutons
- kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361772954P | 2013-03-05 | 2013-03-05 | |
PCT/EP2014/054018 WO2014135474A1 (en) | 2013-03-05 | 2014-03-03 | Inhibitors of bruton's tyrosine kinase |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1218416A1 true HK1218416A1 (zh) | 2017-02-17 |
Family
ID=50190455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16106435.2A HK1218416A1 (zh) | 2013-03-05 | 2016-06-06 | 布魯頓氏酪氨酸激酶抑制劑 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9663494B2 (zh) |
EP (1) | EP2964642B1 (zh) |
JP (1) | JP2016510051A (zh) |
KR (1) | KR101763504B1 (zh) |
CN (1) | CN105143215B (zh) |
BR (1) | BR112015021806A2 (zh) |
CA (1) | CA2903137C (zh) |
HK (1) | HK1218416A1 (zh) |
MX (1) | MX2015010983A (zh) |
RU (1) | RU2015141360A (zh) |
WO (1) | WO2014135474A1 (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2920162B1 (en) * | 2012-11-16 | 2017-04-19 | F. Hoffmann-La Roche AG | Inhibitors of bruton's tyrosine kinase |
US11046670B2 (en) | 2015-10-19 | 2021-06-29 | Board Of Regents, The University Of Texas System | Piperazinyl norbenzomorphan compounds and methods for using the same |
EP3448520A4 (en) * | 2016-04-29 | 2020-07-29 | Board Of Regents, The University Of Texas System | SIGMA RECEIVER BINDERS |
US11100492B2 (en) | 2018-02-19 | 2021-08-24 | Peter Garrett | General purpose re-loadable card aggregation implementation |
IL296734A (en) | 2018-04-13 | 2022-11-01 | The Institute Of Cancer Res Royal Cancer Hospital | bcl6 inhibitors |
CA3202745A1 (en) * | 2020-12-20 | 2022-06-23 | Yi Chen | Btk degrader |
WO2022140246A1 (en) | 2020-12-21 | 2022-06-30 | Hangzhou Jijing Pharmaceutical Technology Limited | Methods and compounds for targeted autophagy |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2426109B1 (en) * | 2007-10-23 | 2013-12-18 | F. Hoffmann-La Roche AG | Novel kinase inhibitors |
DK2242749T3 (da) * | 2008-02-05 | 2013-06-17 | Hoffmann La Roche | Nye pyridinoner og pyridazinoner |
US8299077B2 (en) | 2009-03-02 | 2012-10-30 | Roche Palo Alto Llc | Inhibitors of Bruton's tyrosine kinase |
SG175287A1 (en) * | 2009-04-24 | 2011-11-28 | Hoffmann La Roche | Inhibitors of bruton's tyrosine kinase |
AR082590A1 (es) | 2010-08-12 | 2012-12-19 | Hoffmann La Roche | Inhibidores de la tirosina-quinasa de bruton |
KR20150054994A (ko) * | 2012-09-13 | 2015-05-20 | 에프. 호프만-라 로슈 아게 | 브루톤 티로신 키나아제의 억제제 |
US20150290192A1 (en) * | 2012-11-30 | 2015-10-15 | Hoffmann-La Roche Inc. | Inhibitors of bruton's tyrosine kinase |
-
2014
- 2014-03-03 KR KR1020157026057A patent/KR101763504B1/ko active IP Right Grant
- 2014-03-03 CA CA2903137A patent/CA2903137C/en not_active Expired - Fee Related
- 2014-03-03 BR BR112015021806A patent/BR112015021806A2/pt not_active IP Right Cessation
- 2014-03-03 EP EP14707402.5A patent/EP2964642B1/en not_active Not-in-force
- 2014-03-03 WO PCT/EP2014/054018 patent/WO2014135474A1/en active Application Filing
- 2014-03-03 US US14/768,705 patent/US9663494B2/en not_active Expired - Fee Related
- 2014-03-03 CN CN201480011806.9A patent/CN105143215B/zh not_active Expired - Fee Related
- 2014-03-03 JP JP2015560642A patent/JP2016510051A/ja active Pending
- 2014-03-03 RU RU2015141360A patent/RU2015141360A/ru not_active Application Discontinuation
- 2014-03-03 MX MX2015010983A patent/MX2015010983A/es unknown
-
2016
- 2016-06-06 HK HK16106435.2A patent/HK1218416A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20150376166A1 (en) | 2015-12-31 |
JP2016510051A (ja) | 2016-04-04 |
RU2015141360A (ru) | 2017-04-10 |
BR112015021806A2 (pt) | 2017-07-18 |
US9663494B2 (en) | 2017-05-30 |
MX2015010983A (es) | 2015-10-26 |
EP2964642B1 (en) | 2017-11-15 |
KR20150119944A (ko) | 2015-10-26 |
CN105143215B (zh) | 2017-12-08 |
CA2903137C (en) | 2017-07-18 |
WO2014135474A1 (en) | 2014-09-12 |
KR101763504B1 (ko) | 2017-07-31 |
CN105143215A (zh) | 2015-12-09 |
EP2964642A1 (en) | 2016-01-13 |
CA2903137A1 (en) | 2014-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279258B (en) | tyrosine kinase inhibitors | |
HK1224173A1 (zh) | 布魯頓氏酪氨酸激酶抑制劑和 抑制劑的組合 | |
HK1212689A1 (zh) | 布魯頓氏酪氨酸激酶抑制劑 | |
HK1211293A1 (zh) | 布魯頓氏酪氨酸激酶抑制劑 | |
ZA201603337B (en) | Pyrimidopyrimidinones useful as wee-1 kinase inhibitors | |
HK1220459A1 (zh) | 激酶抑制劑 | |
HK1194381A1 (zh) | 酪氨酸激酶抑制劑 | |
HK1219421A1 (zh) | 激酶抑制劑的組合及其用途 | |
HK1210779A1 (zh) | 酪氨酸激酶抑制劑 | |
SG11201600062RA (en) | Pyrimidine derivatives as kinase inhibitors | |
HK1197060A1 (zh) | 酪氨酸激酶抑制劑 | |
HK1210461A1 (zh) | 布魯頓氏酪氨酸激酶抑制劑 | |
HK1211578A1 (zh) | 作為 激酶抑制劑的酰氨基咪唑並噠嗪 | |
HK1217695A1 (zh) | 布魯頓氏酪氨酸激酶抑制劑 | |
HK1219104A1 (zh) | 激酶抑制劑 | |
EP2988744A4 (en) | THIAZOLE SUBSTITUTED AMINOHETEROARYL COMPOUNDS TYLOSINE KINASE SPLENIC INHIBITORS | |
HK1218416A1 (zh) | 布魯頓氏酪氨酸激酶抑制劑 | |
HK1200816A1 (zh) | 布魯頓酪氨酸激酶抑制劑 | |
IL243295A0 (en) | Carbazole carboxamide compounds are useful as kinase inhibitors | |
EP2968358A4 (en) | NOVEL CHOLINKINASE INHIBITORS | |
HK1215855A1 (zh) | 酪氨酸蛋白激酶抑制劑 | |
EP2968995A4 (en) | INHIBITORS OF LRRK2 KINASE ACTIVITY | |
HK1212975A1 (zh) | 作為布魯頓氏酪氨酸激酶抑制劑的噻唑衍生物 | |
EP2968331A4 (en) | PYRROLOPYRIMIDINE COMPOUNDS AS KINASEINHIBITORS | |
HK1218394A1 (zh) | 酪氨酸蛋白激酶抑制劑 |